Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients

NCT01301157 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

294

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: M518101
DRUG: placebo
DRUG: Dovonex

Sponsor

Maruho Co., Ltd.